Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension.

If you have ocular hypertension, the pressure inside your eye is above normal. Pressure builds because the eye's fluid, known as the aqueous humor, doesn't drain properly. Ocular hypertension ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, it is estimated that 111.8 ...

Some patients with ocular hypertension who develop primary open angle glaucoma experience rapid visual field loss.

Purpose: To review the literature regarding ocular hypertension following intravitreal antivascular endothelial growth factor therapy, and to propose a novel mechanism for the development of ...

Our purpose is to update the comprehensive ophthalmologist about the results of the Ocular Hypertension Treatment Study and the current clinical management of ocular hypertension. In the Ocular ...

H-1337 is under clinical development by D. Western Therapeutics Institute and currently in Phase II for Open-Angle Glaucoma.

Gland Pharma announced its receipt of FDA approval for its latanoprost 0.005% for the treatment of open-angle glaucoma or ocular hypertension. The solution is indicated for reducing elevated ...

A 14-year-old patient presented to the ED with a 12-month history of joint pains and a 2-month history of headaches and ...

After hours: December 27 at 4:20:00 PM EST Loading Chart for OCUL ...

BEDFORD, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development ...